Davis Aaron I. - 03 Sep 2024 Form 4 Insider Report for Tango Therapeutics, Inc. (TNGX)

Role: Other*
Signature: /s/ Davis Aaron I.
Issuer symbol: TNGX
Transactions as of: 03 Sep 2024
Net transactions value: $0
Form type: 4
Filing time: 05 Sep 2024, 21:01:38 UTC
Previous filing: 13 Jun 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TNGX	Stock Option (Right to Buy)	Other	$0	+65,000		$0.000000	65,000	03 Sep 2024	Common Stock	65,000	$10.93	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option, which was granted as compensation for consulting services, shall vest and become exercisable in 2 substantially equal installments, with 32,500 shares vesting as of 12/03/2024 and 32,500 shares vesting as of 03/03/2025, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

Remarks:

The Reporting Person may be deemed member of a group that beneficially owns more than 10% of the outstanding shares of common stock, $0.001 par value per share ("Common Stock"), of Tango Therapeutics, Inc. As to any Reporting Person that is not a beneficial owner of more than 10% of the outstanding shares of Common Stock, this Form 4 shall not be deemed a concession that such person is subject to Section 16 of the Securities Exchange Act of 1934 with respect to the issuer.